Published in J Clin Microbiol on June 23, 2010
Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial. Clin Vaccine Immunol (2011) 1.47
Variation in specificity of HIV rapid diagnostic tests over place and time: an analysis of discordancy data using a Bayesian approach. PLoS One (2013) 1.14
Towards more accurate HIV testing in sub-Saharan Africa: a multi-site evaluation of HIV RDTs and risk factors for false positives. J Int AIDS Soc (2017) 1.04
False positivity of non-targeted infections in malaria rapid diagnostic tests: the case of human african trypanosomiasis. PLoS Negl Trop Dis (2013) 0.99
Accounting for False Positive HIV Tests: Is Visceral Leishmaniasis Responsible? PLoS One (2015) 0.96
The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301). PLoS One (2012) 0.95
Elimination of sleeping sickness hindered by difficult diagnosis. Bull World Health Organ (2013) 0.94
New insights in staging and chemotherapy of African trypanosomiasis and possible contribution of medicinal plants. ScientificWorldJournal (2012) 0.90
Prevalence and types of coinfections in sleeping sickness patients in kenya (2000/2009). J Trop Med (2011) 0.87
Acute Dengue fever causes false-positive reactivity in OraQuick rapid HIV-1/2 antibody test. J Acquir Immune Defic Syndr (2010) 0.85
The role played by alternative splicing in antigenic variability in human endo-parasites. Parasit Vectors (2014) 0.78
A mixed methods study of a health worker training intervention to increase syndromic referral for gambiense human African trypanosomiasis in South Sudan. PLoS Negl Trop Dis (2014) 0.78
HIV misdiagnosis in sub-Saharan Africa: performance of diagnostic algorithms at six testing sites. J Int AIDS Soc (2017) 0.78
Gambiense human african trypanosomiasis and immunological memory: effect on phenotypic lymphocyte profiles and humoral immunity. PLoS Pathog (2014) 0.77
To err is human, to correct is public health: a systematic review examining poor quality testing and misdiagnosis of HIV status. J Int AIDS Soc (2017) 0.77
Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa. J Clin Virol (2014) 0.76
Association of inconclusive sera for human immunodeficiency virus infection with malaria and Epstein-Barr virus infection in Central Africa. J Clin Microbiol (2013) 0.75
Self-reported HIV-positive status but subsequent HIV-negative test result using rapid diagnostic testing algorithms among seven sub-Saharan African military populations. PLoS One (2017) 0.75
Alert, but not alarmed - a comment on "Towards more accurate HIV testing in sub-Saharan Africa: a multi-site evaluation of HIV RDTs and risk factors for false positives (Kosack et al. 2017)". J Int AIDS Soc (2017) 0.75
Designing HIV Testing Algorithms Based on 2015 WHO Guidelines Using Data from Six Sites in sub-Saharan Africa. J Clin Microbiol (2017) 0.75
Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med (2008) 6.70
Association of schistosomiasis with false-positive HIV test results in an African adolescent population. J Clin Microbiol (2010) 1.59
Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis. J Clin Invest (1981) 1.55
How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. J Infect Dis (2010) 1.53
False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol (2006) 1.34
Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J Virol Methods (1995) 1.19
Refrain from telling bad news: patients with leishmaniasis can have false-positive HIV test results. Clin Infect Dis (2007) 1.10
Expression of the B cell repertoire and autoantibodies in human African trypanosomiasis. Clin Exp Immunol (1986) 1.03
Serologic validation of HIV infection in a tropical area. J Acquir Immune Defic Syndr (1993) 1.00
The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki, Zaire. Am J Trop Med Hyg (1992) 0.96
[Polyneuritis and myositis in Trypanosoma gambiense infection]. Dtsch Med Wochenschr (1994) 0.94
Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d'Ivoire. Trans R Soc Trop Med Hyg (1996) 0.91
Clinical problem-solving. Out of Africa. N Engl J Med (2002) 0.87
Absence of relationship between human immunodeficiency virus 1 and sleeping sickness. Trans R Soc Trop Med Hyg (1987) 0.84
Absence of epidemiological inter-relations between HIV infection and African human trypanosomiasis in central Africa. Trop Med Parasitol (1991) 0.82
[Recurrent fever episodes in an African child: diagnostic difficulties of trypanosomiasis in France]. Pediatrie (1992) 0.82
Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS (1993) 3.52
HIV testing in developing countries. Lancet (1997) 2.19
Genotypic subtypes of HIV-1 in Cameroon. AIDS (1994) 1.89
Molecular dipstick test for diagnosis of sleeping sickness. J Clin Microbiol (2006) 1.84
Detection of human immunodeficiency virus type 1 (HIV-1) in heel prick blood on filter paper from children born to HIV-1-seropositive mothers. J Clin Microbiol (1994) 1.81
Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis. Open AIDS J (2008) 1.74
Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides. Clin Chem (1991) 1.73
Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee. AIDS (1992) 1.72
Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. J Infect Dis (1994) 1.54
Review Article: cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up. Trop Med Int Health (2005) 1.52
Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J Virol (1996) 1.41
Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Trans R Soc Trop Med Hyg (2000) 1.35
Genetic and phylogenetic analysis of env subtypes G and H in central Africa. AIDS Res Hum Retroviruses (1994) 1.34
Follow-up of Card Agglutination Trypanosomiasis Test (CATT) positive but apparently aparasitaemic individuals in Côte d'Ivoire: evidence for a complex and heterogeneous population. Trop Med Int Health (2000) 1.27
Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2. J Virol Methods (2010) 1.25
IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Trop Med Int Health (2002) 1.25
Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. AIDS Res Hum Retroviruses (1994) 1.25
Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA. HIV Med (2011) 1.23
Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci (2002) 1.22
Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: a potential human reservoir of parasites? Acta Trop (2006) 1.21
Phylogenetic analysis of a new chimpanzee lentivirus SIVcpz-gab2 from a wild-captured chimpanzee from Gabon. AIDS Res Hum Retroviruses (1994) 1.21
Comparison of different DNA preparation protocols for PCR diagnosis of Human African Trypanosomosis in Côte d'Ivoire. Acta Trop (2002) 1.21
Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J Virol Methods (1995) 1.19
A venue-based HIV prevalence and behavioural study among men who have sex with men in Antwerp and Ghent, Flanders, Belgium, October 2009 to March 2010. Euro Surveill (2011) 1.18
Universal PCR assays for the differential detection of all Old World Leishmania species. Eur J Clin Microbiol Infect Dis (2010) 1.18
Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet (1996) 1.17
Stage determination and therapeutic decision in human African trypanosomiasis: value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire. Trop Med Int Health (2003) 1.13
Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J Virol Methods (1995) 1.11
Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire. Lancet (1992) 1.11
Pediatric human immunodeficiency virus screening in an African district hospital. Clin Diagn Lab Immunol (2005) 1.11
Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses (1995) 1.10
Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. Trans R Soc Trop Med Hyg (2002) 1.10
Comparison of serological tests for Trypanosoma evansi natural infections in water buffaloes from north Vietnam. Vet Parasitol (2000) 1.09
Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J Virol Methods (1997) 1.08
The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa. Lancet Infect Dis (2003) 1.06
Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV. J Virol Methods (2002) 1.06
Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identification. Eur J Clin Microbiol Infect Dis (2011) 1.05
Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J Infect Dis (1995) 1.04
Genetic variation of HIV type 1: relevance of interclade variation to vaccine development. AIDS Res Hum Retroviruses (1998) 1.04
Towards saliva-based screening for sleeping sickness? Trop Med Int Health (2003) 1.02
Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines. Parasitology (2011) 1.01
Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection. J Clin Microbiol (1994) 1.01
Heat-shock protein 70 gene sequencing for Leishmania species typing in European tropical infectious disease clinics. Euro Surveill (2013) 1.00
Genetic variability of HIV type 1 in Kenya. AIDS Res Hum Retroviruses (1994) 0.99
Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire. AIDS (1994) 0.98
Evaluation of whole fresh blood and dried blood on filter paper discs in serological tests for Trypanosoma evansi in experimentally infected water buffaloes. Acta Trop (2002) 0.98
Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei. Eur J Immunol (1996) 0.97
Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon. AIDS (1994) 0.96
Isolation of HIV-1 RNA from plasma: evaluation of eight different extraction methods. J Virol Methods (1996) 0.95
How does Trypanosoma equiperdum fit into the Trypanozoon group? A cluster analysis by RAPD and multiplex-endonuclease genotyping approach. Parasitology (2003) 0.93
Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories. Clin Microbiol Infect (2000) 0.93
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. AIDS Res Hum Retroviruses (2000) 0.92
General expression of RoTat 1.2 variable antigen type in Trypanosoma evansi isolates from different origin. Vet Parasitol (2001) 0.92
Detection of trypanosome-specific antibodies in saliva, towards non-invasive serological diagnosis of sleeping sickness. Trop Med Int Health (2006) 0.92
A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients. Acta Trop (1998) 0.91
Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. AIDS (1996) 0.90
Charting methods to monitor the operational performance of ELISA method for the detection of antibodies against trypanosomes. Vet Parasitol (2001) 0.90
Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant. J Virol (1997) 0.89
Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing. AIDS (1998) 0.89
Evaluation of LATEX/T.b.gambiense for mass screening of Trypanosoma brucei gambiense sleeping sickness in Central Africa. Acta Trop (2003) 0.89
Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol (1997) 0.89
Comparative in vitro isolation of Trypanosoma theileri from cattle in Belgium. Vet Parasitol (2000) 0.89
[Validity, cost and feasibility of the mAECT and CTC confirmation tests after diagnosis of African of sleeping sickness]. Trop Med Int Health (2006) 0.88
Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. AIDS Res Hum Retroviruses (1999) 0.88
Effect of methodology on detection of HIV-1/HIV-2 dual infections in Côte d'Ivoire. J Virol Methods (1994) 0.88
Diagnosis of HIV-1 group O infection by polymerase chain reaction. Lancet (1995) 0.87
Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS (1998) 0.87
Validation of a PCR-oligochromatography test for detection of Trypanozoon parasites in a multicenter collaborative trial. J Clin Microbiol (2007) 0.87
The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment. Int J STD AIDS (2004) 0.87
Genetic comparison of HIV-1 isolates from Africa, Europe, and North America. AIDS Res Hum Retroviruses (1992) 0.86
HIV-1 genetic variability in Cameroon. AIDS (2000) 0.86
Comparison of operational criteria for treatment outcome in gambiense human African trypanosomiasis. Trop Med Int Health (2009) 0.86
Establishment of a panel of reference Trypanosoma evansi and Trypanosoma equiperdum strains for drug screening. Vet Parasitol (2007) 0.86
Interpatient genetic variability of HIV-1 group O. AIDS (1999) 0.86
Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology (2010) 0.85
Using conventional HIV tests on oral fluid. J Virol Methods (2013) 0.85
Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection. Am J Obstet Gynecol (1995) 0.85
Human African trypanosomiasis: a latex agglutination field test for quantifying IgM in cerebrospinal fluid. Bull World Health Organ (1998) 0.84
Virologic and serologic characteristics of a natural chimpanzee lentivirus infection. Virology (1995) 0.84
Biological data and clinical symptoms as predictors of astrogliosis and neurodegeneration in patients with second-stage Trypanosoma brucei gambiense sleeping sickness. Am J Trop Med Hyg (2001) 0.84
The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them. AIDS Res Hum Retroviruses (1997) 0.84
Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees. J Med Primatol (2001) 0.84
Field evaluation of the CATT/Trypanosoma brucei gambiense on blood-impregnated filter papers for diagnosis of human African trypanosomiasis in southern Sudan. Trop Med Int Health (2002) 0.83
Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium. Antivir Ther (2001) 0.83
Recombinant RoTat 1.2 variable surface glycoprotein as antigen for diagnosis of Trypanosoma evansi in dromedary camels. Int J Parasitol (2005) 0.83
Ghibe river basin in Ethiopia: present situation of trypanocidal drug resistance in Trypanosoma congolense using tests in mice and PCR-RFLP. Vet Parasitol (2012) 0.83
Partial characterization of a Hantavirus isolated from a Clethrionomys glareolus captured in Belgium. Acta Virol (1987) 0.83
HIV type 1 C2V3 env diversity among Belgian individuals. AIDS Res Hum Retroviruses (1998) 0.83
Mineralization and mechanical properties of the canine mandible distraction wound following acute molding. Int J Oral Maxillofac Surg (2006) 0.82
[Comparative in vitro studies of self-boring and self-tapping screws. Histomorphological and physical-technical studies of bone layers]. Mund Kiefer Gesichtschir (2000) 0.82
Trypanosoma evansi: cloning and expression in Spodoptera frugiperda [correction of fugiperda] insect cells of the diagnostic antigen RoTat1.2. Exp Parasitol (2001) 0.82
Trypanosoma brucei gambiense: HMI-9 medium containing methylcellulose and human serum supports the continuous axenic in vitro propagation of the bloodstream form. Exp Parasitol (2011) 0.82
Evaluation of an agglutination HIV-1 + 2 antibody assay. J Virol Methods (1995) 0.81
[Diagnosis of sleeping sickness stage: towards a new approach]. Bull Soc Pathol Exot (2002) 0.81
How many different HIV-1 viral load test kits do we need? AIDS (1998) 0.81